Evidence map›Paper›PMID 33548241›Full record

ArticleJournal of molecular and cellular cardiology2021

A peptide of the amino-terminus of GRK2 induces hypertrophy and yet elicits cardioprotection after pressure overload.

Kamila M Bledzka, Iyad H Manaserh, Jessica Grondolsky, Jessica Pfleger, Rajika Roy, Erhe Gao, J Kurt Chuprun, Walter J Koch, Sarah M Schumacher

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. The βCirculation research · 2025
    Article
  3. Review
  4. G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  5. Review
  6. Review
  7. GRK2 in cardiovascular disease and its potential as a therapeutic target.Journal of molecular and cellular cardiology · 2022
    Review
  8. Cardiac GRK2 and the Communicative Axis Between Heart and Fat.JACC. Basic to translational science · 2022
    Article
  9. Article
  10. Emerging therapeutic targets for cardiac hypertrophy.Expert opinion on therapeutic targets · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kamila M BledzkaDepartment of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Iyad H ManaserhDepartment of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Jessica GrondolskyDepartment of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Jessica PflegerCenter for Translational Medicine, Temple University, Philadelphia, PA 19140, USA.
Rajika RoyCenter for Translational Medicine, Temple University, Philadelphia, PA 19140, USA.
Erhe GaoCenter for Translational Medicine, Temple University, Philadelphia, PA 19140, USA.
J Kurt ChuprunCenter for Translational Medicine, Temple University, Philadelphia, PA 19140, USA.
Walter J KochCenter for Translational Medicine, Temple University, Philadelphia, PA 19140, USA; Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Sarah M SchumacherDepartment of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: basss4@ccf.org.
Temple University · USCleveland Clinic Lerner College of Medicine · US

Funding

Regulation of Beta-Adrenergic Receptor Signaling by S-NitrosylationP01HL075443 · NHLBI · DUKE UNIVERSITY · PI XIAO, KUNHONG · 2004 to 2019
$26.1M
Targeting Pathways Involved in Cardiac Injury for Novel Repair StrategiesP01HL147841 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KOCH, WALTER J. · 2020 to 2024
$11.4M
Targeting GRK2 in the HeartR01HL061690 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI KOCH, WALTER J. · 1998 to 2022
$4.2M
Unique Domain Features of GRK2 and Roles in Cardiovascular DiseaseR00HL132882 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI SCHUMACHER, SARAH MARIE · 2018 to 2020
$747k
LTQ-Orbitrap Velos instrumentS10RR031537 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2011 to 2011
$600k
Unique Domain Features of GRK2 and Roles in Cardiovascular DiseaseK99HL132882 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI SCHUMACHER, SARAH MARIE · 2016 to 2017
$229k
NCRR NIH HHS S10 RR031537NHLBI NIH HHS K99 HL132882NHLBI NIH HHS P01 HL075443NHLBI NIH HHS P01 HL147841NHLBI NIH HHS R00 HL132882NHLBI NIH HHS R01 HL061690
6 · The paper itself

Abstract

G protein-coupled receptor (GPCR) kinase 2 (GRK2) expression and activity are elevated early on in response to several forms of cardiovascular stress and are a hallmark of heart failure. Interestingly, though, in addition to its well-characterized role in regulating GPCRs, mounting evidence suggests a GRK2 "interactome" that underlies a great diversity in its functional roles. Several such GRK2 interacting partners are important for adaptive and maladaptive myocyte growth; therefore, an understanding of domain-specific interactions with signaling and regulatory molecules could lead to novel targets for heart failure therapy. Herein, we subjected transgenic mice with cardiac restricted expression of a short, amino terminal fragment of GRK2 (βARKnt) to pressure overload and found that unlike their littermate controls or previous GRK2 fragments, they exhibited an increased left ventricular wall thickness and mass prior to cardiac stress that underwent proportional hypertrophic growth to controls after acute pressure overload. Importantly, despite this enlarged heart, βARKnt mice did not undergo the expected transition to heart failure observed in controls. Further, βARKnt expression limited adverse left ventricular remodeling and increased cell survival signaling. Proteomic analysis to identify βARKnt binding partners that may underlie the improved cardiovascular phenotype uncovered a selective functional interaction of both endogenous GRK2 and βARKnt with AKT substrate of 160 kDa (AS160). AS160 has emerged as a key downstream regulator of insulin signaling, integrating physiological and metabolic cues to couple energy demand to membrane recruitment of Glut4. Our preliminary data indicate that in βARKnt mice, cardiomyocyte insulin signaling is improved during stress, with a coordinate increase in spare respiratory activity and ATP production without metabolite switching. Surprisingly, these studies also revealed a significant decrease in gonadal fat weight, equivalent to human abdominal fat, in male βARKnt mice at baseline and following cardiac stress. These data suggest that the enhanced AS160-mediated signaling in the βARKnt mice may ameliorate pathological cardiac remodeling through direct modulation of insulin signaling within cardiomyocytes, and translate these to beneficial effects on systemic metabolism.

Indexed as

Protein Interaction Domains and MotifsAnimalsBiomarkersCardiomegalyDisease Models, AnimalDisease SusceptibilityGene ExpressionG-Protein-Coupled Receptor Kinase 2MiceMice, TransgenicPeptidesPhenotypeProtein BindingSignal TransductionVentricular RemodelingBiomarkersG-Protein-Coupled Receptor Kinase 2GRK2 protein, mousePeptidesGRK2Heart failureHypertrophyPhysiologicalProteomics

Identifiers

PMID33548241
PMCPMC8101069
OpenAlexW3128435127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.